tiprankstipranks
Trending News
More News >
Myriad Genetics (MYGN)
NASDAQ:MYGN
US Market
Advertisement

Myriad Genetics (MYGN) Drug Pipeline

Compare
416 Followers
Drug Name
Condition
Stage
Status
Study Name
Trial Start Date
Article
Pembrolizumab, Skb264
Solid Tumor
Phase II
Active Not Recruiting
SKB264 in Combination With Pembrolizumab in Subjects With Selected Solid Tumors
Nov 30, 2022
Ethanol, Melphalan, Bcnu, Vitamin B12b, Vitamin C, Autologous Hematopoietic Stem Cells
Pancreatic Ductal Adenocarcinoma, Metastatic Pancreatic Cancer, Pancreatic Cancer Stage Iv, Pancreatic Cancer, Her2-Negative Breast Cancer, Breast Cancer Metastatic, Metastatic Pancreatic Ductal Adenocarcinoma, Pancreatic Adenocarcinoma Metastatic, Brca1 Mutation, Brca2 Mutation, Pancreatic Acinar Cell Carcinoma, Breast Cancer Stage Iv, Her2 Negative Breast Carcinoma, Adenocarcinoma Of The Breast, Palb2 Gene Mutation
Phase I
Recruiting
SHARON: A Clinical Trial for Metastatic Cancer With a BRCA or PALB2 Mutation Using Chemotherapy and Patients' Own Stem Cells
Oct 30, 2019
Temozolomide, Pamiparib
Locally Advanced Or Metastatic Solid Tumors
Phase I
Completed
Study to Assess Safety, Tolerability and Clinical Activity of BGB-290 in Combination With Temozolomide (TMZ) in Participants With Locally Advanced or Metastatic Solid Tumors
May 08, 2017
Niraparib
Ovarian Neoplasms
Phase III
Active Not Recruiting
A Study of Niraparib (GSK3985771) Maintenance Treatment in Participants With Advanced Ovarian Cancer Following Response on Front-Line Platinum-Based Chemotherapy
Dec 08, 2015

FAQ

What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
    What is a clinical trial?
    A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
      What drugs does Myriad Genetics (MYGN) have in its pipeline
      MYGN is currently developing the following drugs: Pembrolizumab, Skb264, Ethanol, Melphalan, Bcnu, Vitamin B12b, Vitamin C, Autologous Hematopoietic Stem Cells, Temozolomide, Pamiparib. These drug candidates are in various stages of clinical development as the company works toward FDA approval.
        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis